Surrogate end points in cardiovascular disease trials.
Fleming
T R
TR
Department of Biostatistics, University of Washington, Seattle, WA 98195, USA.
D002318:Cardiovascular Diseases / Q000188:drug therapy* / Q000401:mortality; D017322:Clinical Trials, Phase II as Topic / Q000706:statistics & numerical data*; D017326:Clinical Trials, Phase III as Topic / Q000706:statistics & numerical data*; D003627:Data Interpretation, Statistical; D006801:Humans; D015203:Reproducibility of Results; D016019:Survival Analysis